Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 293 insiders at 194 companies
- $6.3B sold by 282 insiders outside a trading plan
- $3.3B sold by 627 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Michael S Williams CEOMTUSMetallus Inc.Planned sale$251K 12,570 shares at $20.01 1.7% of stakeTraded Oct 2 Filed Oct 2
-
Allan C. Thygesen CEODOCUDocuSign, Inc.Planned sale$1.8M 26,250 shares at $69.29 14% of stakeTraded Oct 1 Filed Oct 2
-
Lawrence Otto Klein CEOORKAOruka Therapeutics, Inc.Planned sale$2.1M 25,000 shares at $83.62 2.6% of stakeTraded Oct 1 Filed Oct 2
-
Frederick G Thiel CEOMARAMARA Holdings, Inc.Planned sale$309K 27,505 shares at $11.22 0.6% of stakeTraded Oct 1 Filed Oct 2
-
Spenser Skates CEOAMPLAmplitude, Inc.Planned sale$71K 4,913 shares at $14.45 100% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.3M 20,000 shares at $265.46 0.3% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Jon Congleton CEOMLYSMineralys Therapeutics, Inc.Planned sale$1.9M 75,000 shares at $25.46 12% of stakeTraded Sep 30 Filed Oct 2
-
Scott Bender CEOWHDCactus, Inc.Planned sale$6.2M 100,000 shares at $61.97 45% of stakeTraded Oct 1 Filed Oct 2
-
Eric Venker CEOROIVRoivant Sciences Ltd.Planned sale$7.3M 200,000 shares at $36.62 11% of stakeTraded Sep 30 Filed Oct 2
-
Amit Gupta CEOCDLXCardlytics, Inc.Sale$47K 17,733 shares at $2.64 11% of stakeTraded Oct 1–2 Filed Oct 2
-
Dan Paterson CEOVSTMVerastem, Inc.Planned sale$353K 44,121 shares at $8.00 6.3% of stakeTraded Oct 1 Filed Oct 2
-
Gregory M. Hart CEOCOURCoursera, Inc.Planned sale$53K 10,308 shares at $5.11 0.7% of stakeTraded Oct 1 Filed Oct 2
-
Aaron Jagdfeld CEOGNRCGenerac Holdings Inc.Planned sale$1M 5,000 shares at $206.00 0.9% of stakeTraded Oct 1 Filed Oct 2
-
Neil Harris Blumenthal CEOWRBYWarby Parker Inc.Planned sale$2.8M 100,000 shares at $27.69 74% of stakeTraded Oct 1 Filed Oct 2
-
Ryan Cohen CEOGMEGameStop CorporationBuy$17.1M 700,000 shares at $24.41 +1.7% to stakeTraded Oct 2 Filed Oct 2
-
Daniel Patrick O'Day CEOGILDGilead Sciences Inc.Planned sale$2.2M 15,000 shares at $147.90 2.6% of stakeTraded Oct 1 Filed Oct 2
-
Timothy J. Mattke CEOMTGMGIC Investment CorporationPlanned sale$3.6M 137,114 shares at $26.24 14% of stakeTraded Oct 1 Filed Oct 2
-
Natascha Viljoen CEONEMNewmont CorporationPlanned sale$446K 3,882 shares at $114.81 3% of stakeTraded Oct 1 Filed Oct 2
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$5.5M 9,500 shares at $576.47 2.8% of stakeTraded Oct 1 Filed Oct 2
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$3.3M 34,000 shares at $97.09 16% of stakeTraded Oct 1–2 Filed Oct 2
-
John Sheldon Serafini CEOHAWKHawkEye 360, Inc.Planned sale$1.4M 92,329 shares at $14.78 14% of stakeTraded Oct 1 Filed Oct 2
-
Conor Murphy CEOFGF&G Annuities & Life, Inc.Buy$5,015 231 shares at $21.68 +0.1% to stakeTraded Sep 30 Filed Oct 2
-
Edward Meyercord CEOEXTRExtreme Networks, Inc.Planned sale$1.1M 50,000 shares at $21.77 2.8% of stakeTraded Oct 1 Filed Oct 2
-
Jason V Coloma CEOMAZEMaze Therapeutics, Inc.Planned sale$932K 34,501 shares at $27.02 15% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$10.3M 11,002 shares at $935.60 2.9% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$17.4M 18,998 shares at $914.67 4.8% of stakeTraded Oct 1 Filed Oct 2
-
Lee Shavel CEOVRSKVerisk Analytics, Inc.Planned sale$603K 3,535 shares at $170.70 3.5% of stakeTraded Oct 1 Filed Oct 2
-
Ralph A LaRossa CEOPEGPublic Service Enterprise Group IncorporatedPlanned sale$141K 2,083 shares at $67.48 0.7% of stakeTraded Oct 1 Filed Oct 2
-
John T Hall CEOINTAIntapp, Inc.Planned sale$110K 3,000 shares at $36.70 0.1% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Kun Dai CEOUXINUxin LimitedBuy$13K 9,000 shares at $1.42 +57% to stakeTraded Oct 1 Filed Oct 2
-
Satish Dhanasekaran CEOKEYSKeysight Technologies Inc.Sale$1.1M 3,000 shares at $364.13 2.5% of stakeTraded Sep 30 Filed Oct 2
-
Sanjit Biswas CEOIOTSamsara Inc.Planned sale$10M 263,900 shares at $38.03 23% of stakeTraded Sep 29–Oct 1 Filed Oct 1
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$26.7M 307,692 shares at $86.65Traded Sep 29 Filed Oct 1
-
Steve Ladd Huffman CEORDDTReddit, Inc.Planned sale$2.5M 17,308 shares at $144.87 4.9% of stakeTraded Sep 29 Filed Oct 1
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$30.3M 48,667 shares at $623.03 13% of stakeTraded Sep 29–30 Filed Oct 1
-
Brian J Roney CEOPRHIPresurance Holdings, Inc.Buy$51K 7,500 shares at $6.75 +10% to stakeTraded Sep 30 Filed Oct 1
-
Cesar Nivaldo Gon CEOCINTCI&T IncBuy$20K 6,684 shares at $3.01 +8.9% to stakeTraded Sep 29–30 Filed Oct 1
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$1.1M 1,920 shares at $550.22 0.6% of stakeTraded Sep 30 Filed Oct 1
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$3.9M 7,580 shares at $517.97 2.3% of stakeTraded Sep 30 Filed Oct 1
-
Nello Mainolfi CEOKYMRKymera Therapeutics, Inc.Planned sale$3.4M 30,000 shares at $113.80 4.3% of stakeTraded Oct 1 Filed Oct 1
-
William Staples CEOGTLBGitLab Inc.Buy$125K 2,677 shares at $46.62 +0.4% to stakeTraded Sep 30 Filed Oct 1
-
George Kurian CEONTAPNetApp, Inc.Planned sale$10.5M 50,000 shares at $209.95 19% of stakeTraded Sep 29 Filed Oct 1
-
Matthew J Cox CEOMATXMatson, Inc.Planned sale$2.2M 10,000 shares at $222.33 4.4% of stakeTraded Sep 29 Filed Oct 1
-
Glen R Ives CEOCTMCastellum, Inc.Buy$910 1,700 shares at $0.5400 +0.8% to stakeTraded Oct 1 Filed Oct 1
-
Alejandro Gustavo Elsztain CEOCRESYCresud S.A.C.I.F. y A.Buy$199K 17,334 shares at $11.50 +1.4% to stakeTraded Sep 30–Oct 1 Filed Oct 1
-
Scott Mezvinsky CEOYUMYum! Brands, Inc.Planned sale$33K 241 shares at $136.89 100% of stakeTraded Oct 1 Filed Oct 1
-
Ian Mortimer CEOXENEXenon Pharmaceuticals Inc.Buy$1.1M 30,000 shares at $37.38 +151% to stakeTraded Sep 30 Filed Oct 1
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$278K 306,813 shares at $0.9100 +30% to stakeTraded Sep 29–30 Filed Oct 1
-
Kun Dai CEOUXINUxin LimitedBuy$9,945 7,443 shares at $1.34 +88% to stakeTraded Sep 30 Filed Oct 1
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.2M 20,000 shares at $258.20 0.3% of stakeTraded Sep 28–29 Filed Sep 30
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.